Collectively, these data suggest that tumor cell-produced inflammatory cytokines activate both Wnt/β-catenin and NF-κB pathways of the same line of tumor cells, which in turn enhance inflammatory cytokine production, forming an autocrine forward-feedback loop to promote CSC enrichment after chemotherapy withdrawal. Here, NFKB1 is linked to neoplasm.